Amid increasing cases of Mucoramycosis in the country, a domestic company has announced the introduction of its new medicine. Hyderabad-based MSN Laboratories has announced the launch of Posaconazole in the Indian market. The company has announced the introduction of this drug in the form of 100 mg delayed-release tablets and 300 mg injections. Many patients recovering from Kovid-19 have been found to have a rare and lethal fungal infection called mucormycosis, popularly known as a black fungus. The company claims that its drug has been approved by the Controller General of Indian Medicine ([DCGI)].
Amphotericin-B availability being increased
Given the increasing cases of black fungus, mucormycosis, the government has also started increasing the availability of key amphotericin-B in its treatment. It has been said by the government that the supply of Amphotericin-B drugs in the country was limited, but now its supply is being increased continuously. To increase its availability, the government has already approved the production of five more companies. Apart from this, the existing companies are also increasing their production capacity.
How does black fungus spread?
The black fungus also damages the nose, eyes, sinuses, and sometimes the brain. There are very few cases of black fungus infection in humans. The black fungus occurs in soil, plants, spoiled fruits, and vegetables, and sometimes humans also get infected after coming into contact with it. Doctors say that steroid is being used to treat corona infection. Steroid affects immunity and black fungus catches only those with weak immunity. This is the reason why most patients recovering from corona, especially diabetic patients are prone to black fungus.